Advertisement
ACRS vs STRRP
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRS is a StrongBuy and STRRP is a StrongBuy.
Momentum Indicator for ACRS turns positive, indicating new upward trend
ACRS saw its Momentum Indicator move above the 0 level on October 20, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned positive. In 78 of the 92 cases, the stock moved higher in the following days. The odds of a move higher are at 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ACRS's RSI Indicator exited the oversold zone, 25 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 49 of 60 cases where ACRS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for ACRS just turned positive on October 21, 2026. Looking at past instances where ACRS's MACD turned positive, the stock continued to rise in 34 of 43 cases over the following month. The odds of a continued upward trend are 79%.
Following a +9.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where ACRS advanced for three days, in 224 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
ACRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for ACRS entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.502) is normal, around the industry mean (2.988). P/E Ratio (-6.569) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (83.333) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. ACRS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
STRRP's RSI Oscillator slumps into oversold zone
The RSI Oscillator for STRRP moved into overbought territory on October 21, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.26% 3-day Advance, the price is estimated to grow further. Considering data from situations where STRRP advanced for three days, in 77 of 179 cases, the price rose further within the following month. The odds of a continued upward trend are 43%.
STRRP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on STRRP as a result. In 62 of 137 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 45%.
The Moving Average Convergence Divergence Histogram (MACD) for STRRP turned negative on September 25, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 69 similar instances when the indicator turned negative. In 32 of the 69 cases the stock turned lower in the days that followed. This puts the odds of success at 46%.
STRRP moved below its 50-day moving average on September 25, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where STRRP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 35%.
The Aroon Indicator for STRRP entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (4.843). P/E Ratio (0.000) is within average values for comparable stocks, (0.837). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.448). Dividend Yield (0.113) settles around the average of (1.377) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (0.884).
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. STRRP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STRRP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
ACRS | STRRP | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 67 | 76 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 37 Fair valued | 11 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 100 | |
PRICE GROWTH RATING 1..100 | 63 | 59 | |
P/E GROWTH RATING 1..100 | 15 | 100 | |
SEASONALITY SCORE 1..100 | 27 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
STRRP's Valuation (11) in the null industry is in the same range as ACRS (37) in the Pharmaceuticals Other industry. This means that STRRP’s stock grew similarly to ACRS’s over the last 12 months.
STRRP's Profit vs Risk Rating (100) in the null industry is in the same range as ACRS (100) in the Pharmaceuticals Other industry. This means that STRRP’s stock grew similarly to ACRS’s over the last 12 months.
ACRS's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as STRRP (100) in the null industry. This means that ACRS’s stock grew similarly to STRRP’s over the last 12 months.
STRRP's Price Growth Rating (59) in the null industry is in the same range as ACRS (63) in the Pharmaceuticals Other industry. This means that STRRP’s stock grew similarly to ACRS’s over the last 12 months.
ACRS's P/E Growth Rating (15) in the Pharmaceuticals Other industry is significantly better than the same rating for STRRP (100) in the null industry. This means that ACRS’s stock grew significantly faster than STRRP’s over the last 12 months.
| ACRS | STRRP | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 83% | 2 days ago 75% |
| Stochastic ODDS (%) | 2 days ago 82% | 2 days ago 45% |
| Momentum ODDS (%) | 2 days ago 85% | 2 days ago 45% |
| MACD ODDS (%) | 2 days ago 79% | 2 days ago 46% |
| TrendWeek ODDS (%) | 2 days ago 84% | 2 days ago 34% |
| TrendMonth ODDS (%) | 2 days ago 77% | 2 days ago 37% |
| Advances ODDS (%) | 2 days ago 82% | about 1 month ago 43% |
| Declines ODDS (%) | 9 days ago 84% | 2 days ago 35% |
| BollingerBands ODDS (%) | 2 days ago 84% | 2 days ago 74% |
| Aroon ODDS (%) | 2 days ago 78% | 2 days ago 61% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ACRS’s FA Score shows that 1 FA rating(s) are green while STRRP’s FA Score has 1 green FA rating(s).
- ACRS’s FA Score: 1 green, 4 red.
- STRRP’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ACRS’s TA Score shows that 6 TA indicator(s) are bullish while STRRP’s TA Score has 4 bullish TA indicator(s).
- ACRS’s TA Score: 6 bullish, 2 bearish.
- STRRP’s TA Score: 4 bullish, 5 bearish.
Price Growth
ACRS (@Biotechnology) experienced а +12.72% price change this week, while STRRP (@Other Consumer Services) price change was -2.43% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.
The average weekly price growth across all stocks in the @Other Consumer Services industry was +1.88%. For the same industry, the average monthly price growth was -5.92%, and the average quarterly price growth was +21.04%.
Reported Earning Dates
ACRS is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Biotechnology (-1.10% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Other Consumer Services (+1.88% weekly)Other consumer services include companies that provide consumer services, and are not classified elsewhere. Travel fare aggregators, hotel bookings, consumer-to-consumer or business-to-business sales platforms are some examples of services that can be clubbed into this category. Many of such services have expanded online. Booking Holdings Inc, The Priceline Group Inc, and eBay Inc. are some major operators in this segment.
Advertisement
STRRP and
Correlation & Price change
A.I.dvisor indicates that over the last year, STRRP has been closely correlated with CVRX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if STRRP jumps, then CVRX could also see price increases.
| Ticker / NAME | Correlation To STRRP | 1D Price Change % | ||
|---|---|---|---|---|
| STRRP | 100% | -2.43% | ||
| CVRX - STRRP | 67% Closely correlated | -1.44% | ||
| ACRS - STRRP | 52% Loosely correlated | +1.06% | ||
| ANGO - STRRP | 48% Loosely correlated | +0.68% | ||
| ELUT - STRRP | 46% Loosely correlated | +1.52% | ||
| INGN - STRRP | 44% Loosely correlated | -0.30% | ||
More | ||||